BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8424935)

  • 1. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
    Yamamoto K; Sugiyama H; Kawanishi S
    Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
    Isomura M; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.
    Sugiyama H; Lian C; Isomura M; Saito I; Wang AH
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14405-10. PubMed ID: 8962064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
    Yamamoto K; Kawanishi S
    Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
    Sugiyama H; Lam CK; Hosoda M; Saito I
    Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distamycin A enhances the cytotoxicity of duocarmycin A and suppresses duocarmycin A-induced apoptosis in human lung carcinoma cells.
    Hirota M; Fujiwara T; Mineshita S; Sugiyama H; Teraoka H
    Int J Biochem Cell Biol; 2007; 39(5):988-96. PubMed ID: 17321782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
    Ozeki Y; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry of drug-induced DNA lesions.
    Saito I
    Toxicol Lett; 1993 Apr; 67(1-3):3-15. PubMed ID: 8451767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-selective guanine reactivity by duocarmycin A.
    Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
    Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the covalent duocarmycin A-DNA duplex complex.
    Lin CH; Patel DJ
    J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
    Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
    Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
    Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
    Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
    Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
    Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
    Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
    Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(2-chloroethyl)-N-nitrosoureas covalently bound to nonionic and monocationic lexitropsin dipeptides. Synthesis, DNA affinity binding characteristics, and reactions with 32P-end-labeled DNA.
    Church KM; Wurdeman RL; Zhang Y; Chen FX; Gold B
    Biochemistry; 1990 Jul; 29(29):6827-38. PubMed ID: 2168742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation.
    Wyatt MD; Lee M; Hartley JA
    Nucleic Acids Res; 1997 Jun; 25(12):2359-64. PubMed ID: 9171086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative analysis of DNA methylation at N3-adenine by N-methyl-N-nitrosourea.
    Kelly JD; Shah D; Chen FX; Wurdeman R; Gold B
    Chem Res Toxicol; 1998 Dec; 11(12):1481-6. PubMed ID: 9860491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
    Ginsburg H; Nissani E; Krugliak M; Williamson DH
    Mol Biochem Parasitol; 1993 Mar; 58(1):7-15. PubMed ID: 7681547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of lambda cro repressor with synthetic operator OR3 studied by competition binding with minor groove binders.
    Gursky GV; Surovaya AN; Kurochkin AV; Chernov BK; Volkov SK; Kirpichnikov MP
    J Biomol Struct Dyn; 1992 Aug; 10(1):15-33. PubMed ID: 1329842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.